IASIBON
50 Milligram Film Coated Tablet
Compare
|
EU/1/10/659/001-002&8-10
Authorised: 21/01/2011
Pharmathen S.A.
|
SPC
PIL
IPAR
|
IASIBON
1 Milligram Concentrate for Soln for Inf
Compare
|
EU/1/10/659/003
Authorised: 21/01/2011
Pharmathen S.A.
|
SPC
PIL
IPAR
|
IASIBON
2 Milligram Concentrate for Soln for Inf
Compare
|
EU/1/10/659/004
Authorised: 21/01/2011
Pharmathen S.A.
|
SPC
PIL
IPAR
|
IASIBON
6 Milligram Concentrate for Soln for Inf
Compare
|
EU/1/10/659/005-007
Authorised: 21/01/2011
Pharmathen S.A.
|
SPC
PIL
IPAR
|
Ibandronic Acid 150 mg film-coated tablets
150 milligram(s) Film-coated tablet
Compare
|
PA2315/184/001
Authorised: 21/01/2011
Accord Healthcare Ireland Ltd.
|
SPC
|
Ibandronic Acid 6 mg Concentrate for Solution for Infusion
6 milligram(s) Concentrate for solution for infusion
Compare
|
PA1122/018/001
Authorised: 03/05/2013
Noridem Enterprises Ltd
|
SPC
PIL
|
Ibandronic acid Accord
2 milligram(s) Concentrate for solution for infusion
Compare
|
EU/1/12/798/001
Accord Healthcare S.L.U.
|
SPC
PIL
IPAR
EdM
|
Ibandronic acid Accord
6 milligram(s) Concentrate for solution for infusion
Compare
|
EU/1/12/798/002-004
Accord Healthcare S.L.U.
|
SPC
PIL
IPAR
EdM
|
Ibandronic acid Accord
3 milligram(s) Solution for injection
Compare
|
EU/1/12/798/005-006
Accord Healthcare S.L.U.
|
SPC
PIL
IPAR
EdM
|
Ibandronic Acid Clonmel 150 mg film-coated tablets
150 milligram(s) Film-coated tablet
Compare
|
PA0126/240/001
Authorised: 28/01/2011
Clonmel Healthcare Ltd
|
SPC
PIL
|
Ibandronic Acid Mylan 150 mg Film-coated Tablets
150 milligram(s) Film-coated tablet
Compare
|
PA0577/111/001
Authorised: 02/07/2010
McDermott Laboratories Ltd., T/A Gerard Laboratories
|
SPC
PIL
|
IBANDRONIC ACID SANDOZ
50 Milligram Film Coated Tablet
Compare
|
EU/1/11/685/001-005
Authorised: 26/07/2011
Sandoz GmbH
|
SPC
PIL
IPAR
|
IBANDRONIC ACID TEVA
50 Milligram Film Coated Tablet
Compare
|
EU/1/10/642/001-002
Authorised: 17/09/2010
Teva B.V.
|
SPC
PIL
IPAR
|
IBANDRONIC ACID TEVA
150 Milligram Film Coated Tablet
Compare
|
EU/1/10/642/003-004
Authorised: 17/09/2010
Teva B.V.
|
SPC
PIL
IPAR
|
Ibrance
75 milligram(s) Capsule, hard
Compare
|
EU/1/16/1147/001-002
Authorised: 09/11/2016
Pfizer Limited
|
SPC
PIL
IPAR
|
Ibrance
100 milligram(s) Film-coated tablet
Compare
|
EU/1/16/1147/0012-013
Authorised: 13/02/2020
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Ibrance
100 milligram(s) Capsule, hard
Compare
|
EU/1/16/1147/003-004
Authorised: 09/11/2016
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Ibrance
125 milligram(s) Capsule, hard
Compare
|
EU/1/16/1147/005-006
Authorised: 09/11/2016
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Ibrance
75 milligram(s) Film-coated tablet
Compare
|
EU/1/16/1147/010-011
Authorised: 13/02/2020
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|
Ibrance
125 milligram(s) Film-coated tablet
Compare
|
EU/1/16/1147/014-015
Authorised: 13/02/2020
Pfizer Europe MA EEIG
|
SPC
PIL
IPAR
|